Regulation  

What was once a red and blue issue has now attracted a growing set of proponents from both sides of the aisle.

Bitcoin is on the rise again Thursday. Here's what you need to know.

Nickel prices have rallied to a three-year high this week.

Bitcoin trades higher Wednesday. Here's what you need to know.

Ultragenyx scored its second FDA drug approval in six months. The orphan disease specialist also picked up its second Rare Pediatric Disease Priority Review Voucher; its first sold for $130 million.

Aluminum prices soar to a seven-year high on Wednesday.

Two weeks ago, the agency told Alkermes it needed more trials for antidepressant drug candidate ALKS-5461. The agency, however, had a change of heart, sending shares jumping on the news.

University of Chicago professor Dennis Carlton took aim at a model that University of California Berkeley economist Carl Shapiro created for the government.

McKesson and other drug distributors are having a difficult time steering clear of controversy, with the latest blow a lawsuit alleging McKesson has violated the False Claims Act.

Just days after adding new members to its board, Deutsche Bank replaced CEO John Cryan and named Christian Sewing, who co-led the private and commercial bank, to take over.